 |
Geneos Therapeutics
Last updated: March 04, 2024
Founder Niranjan Y. Sardesai
Country: USA | Funding: $49.5M (+)
Website: https://geneostx.com/
Geneos is developing personalized immunotherapies against tumor specific neoantigens which arise from gene mutations in cancerous cells. These mutations form during the development and progression of cancer.
Website: https://geneostx.com/
Geneos is developing personalized immunotherapies against tumor specific neoantigens which arise from gene mutations in cancerous cells. These mutations form during the development and progression of cancer.
